Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder.

Baldwin, D.S., Buis, C. and Mayers, A.G., 2002. Selective serotonin reuptake inhibitors in the treatment of generalized anxiety disorder. Expert Review of Neurotherapeutics, 2 (5), pp. 717-724.

This is the latest version of this eprint.

Full text available as:

[img]PDF
132kB

DOI: 10.1586/14737175.2.5.717

Abstract

Selective serotonin reuptake inhibitors have proven efficacy in the treatment of panic disorder, obsessive–compulsive disorder, post-traumatic stress disorder and social anxiety disorder. Accumulating data shows that selective serotonin reuptake inhibitor treatment can also be efficacious in patients with generalized anxiety disorder. This review summarizes the findings of randomized controlled trials of selective serotonin reuptake inhibitor treatment for generalized anxiety disorder, examines the strengths and weaknesses of other therapeutic approaches and considers potential new treatments for patients with this chronic and disabling anxiety disorder.

Item Type:Article
ISSN:1473-7175
Subjects:Technology > Medicine and Health
Psychology
Group:Faculty of Science and Technology
ID Code:17267
Deposited By:Dr Andrew Mayers
Deposited On:31 Jan 2011 16:03
Last Modified:10 Sep 2014 15:51

Available Versions of this Item

Document Downloads

More statistics for this item...
Repository Staff Only -
BU Staff Only -
Help Guide - Editing Your Items in BURO